2022 annual financial data
Biodexa Pharmaceuticals 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,008.3%.
Operating income was -8,932,000 GBP and net income was -7,656,000 GBP.
Operating cash flow was -7,048,000 GBP.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 699,000 GBP
- Operating income
- -8,932,000 GBP
- Net income
- -7,656,000 GBP
- Operating cash flow
- -7,048,000 GBP